Jiahe Ouyang
The United Innovation Of Mengchao Hepatobiliary Technology Key Laboratory Of Fujian Province
Fuzhou, 350025, China
Fuzhou, 350025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Urinary Proteomics Enables Non-Invasive and Longitudinal Monitoring of Tumor Burden Dynamics and Early Recurrence in HCC.
Journal: Molecular & cellular proteomics : MCP
Published: December 23, 2025
Mass spectrometry-based de novo sequencing reveals non-canonical neoantigens with antitumor efficacy in hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: February 24, 2025
High-Throughput Proteomics Reveals a Novel Small Open Reading Frame-Encoded Peptide That Promotes Hepatocellular Carcinoma Invasion and Migration.
Journal: Journal of proteome research
Published: February 07, 2025
Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma.
Journal: Journal of proteome research
Published: February 19, 2024
Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma.
Journal: Nature communications
Published: October 11, 2023
Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy.
Journal: Cell reports. Medicine
Published: December 07, 2022
Alcohol reshapes a liver premetastatic niche for cancer by extra- and intrahepatic crosstalk-mediated immune evasion.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 30, 2022
Personalized neoantigen vaccine combined with PD-1 blockade increases CD8+ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models.
Journal: Journal for immunotherapy of cancer
Published: August 30, 2022
Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential.
Journal: Journal of proteomics
Published: November 20, 2019
4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC.
Journal: Cancer management and research
Published: September 12, 2019
Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma.
Journal: Genomics, proteomics & bioinformatics
Published: February 21, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026